References

1. Humbert M, Khaltaev N, Bousquet J, et al. Pulmonary hypertension: From an orphan disease to a public health problem. Chest 2007;132;365-367.
2. Girgis RE. Emerging drugs for pulmonary hypertension. Expert Opin Emerg Drugs. 2010;15(1):71-85.
3. Benedict N, Seybert A, Mathier MA. Evidence-based pharmacologic management of pulmonary arterial hypertension. Clin Ther. 2007;29(10):2134-53.
4. Humbert M, Morrell N, Archer S, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12):S13-24.
5. Symptoms. Pulmonary Hypertension Association. http://www.phassociation.org/Page.aspx?pid=974. Accessed February 22, 2010.
6. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. J. Am. Coll. Cardiol. 2009;53(17):1573-619.
7. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(suppl 1):S43-S54.
8. What is Cardiac Catheterization? National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/cath/. Accessed February 22, 2010.
9. Humbert M, Sitbon O, Simonneau G. Drug therapy: treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351(14):1425-36.
10. Galiè N, Torbicki A, Barst R, et al; The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. Eur Heart J. 2004;25:2243-78.
11. Takaoka S, Faul JL, Doyle R. Current therapies for pulmonary arterial hypertension. Sem. In Cardiothoracic Vascular Anesthesia. 2007;11(2):137-48.
12. Controlling Salt and Sodium Consumption. Pulmonary Hypertension Association. http://www.phassociation.org/Page.aspx?pid=1604. Accessed February 22, 2010.
13. Monitoring Your Fluid Intake. Pulmonary Hypertension Association. http://www.phassociation.org/Page.aspx?pid=1605. Accessed February 22, 2010.
14. Managing Nausea and Vomiting. Pulmonary Hypertension Association. http://www.phassociation.org/Page.aspx?pid=1607. Accessed February 22, 2010.
15. Exercise and PH. Pulmonary Hypertension Association. http://www.phassociation.org/Page.aspx?pid=1520. Accessed February 22, 2010.
16. Mubarak KK. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension. Respir Med. 2010;104:9-21.
17. Gomberg-Maitland M, Olschewski H. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J. 2008;31:891-901.
18. O´Callaghan DS, et al. Treatment of pulmonary arterial hypertension with targeted therapies. Nat Rev Cardiol. 2011;8:526-538.
19. Tuder RM, et al. Prostacyclin synthase expression in decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med. 1999;159:1952-1932.